Abstract

BackgroundInfluenza and respiratory syncytial virus (RSV) are among the leading causes of lower respiratory tract infections worldwide. We conducted a comparative analysis of the age distribution and spatiotemporal epidemiology of influenza and RSV in Russia using sentinel surveillance data from 2013-14 to 2018-19 in six cities located in the western, central, and eastern regions of the country.MethodsWe calculated the positivity rate for influenza and RSV (by month, season, and overall) in each city, separately for patients seen at the primary and secondary care level (out-patients medical centres housing GP practices and infectious diseases hospitals, respectively). We compared the age distribution of patients infected with the different influenza virus (sub)types and RSV.ResultsA total of 17 551 respiratory specimens were included: the overall positivity rate was 13.5% for influenza and 4.4% for RSV. The A(H1N1)pdm09, A(H3N2) and B virus (sub)types caused 31.3%, 44.0% and, respectively, 24.7% of all influenza cases. The median age was older among influenza (15 years) than among RSV patients (3 years); differences across influenza virus (sub)types were seen only at the primary care level, with influenza A(H3N2) patients being significantly older than A(H1N1)pdm09 or B influenza patients. The timing of influenza epidemics was similar across cities, with the peak typically occurring in February or March. In contrast, the typical peak timing of RSV epidemics varied largely across cities, and the virus was often detected also in spring and summer months (unlike influenza).ConclusionsInfluenza and RSV epidemiology differed in many regards in Russia, especially in the timing of epidemics and the age distribution of infected subjects. Health policies aimed at containing the burden of diseases of viral respiratory infections in Russia should take these findings into account.

Highlights

  • MethodsWe calculated the positivity rate for influenza and respiratory syncytial virus (RSV) (by month, season, and overall) in each city, separately for patients seen at the primary and secondary care level (out-patients medical centres housing GP practices and infectious diseases hospitals, respectively)

  • Influenza and respiratory syncytial virus (RSV) are among the leading causes of lower respiratory tract infections worldwide

  • Influenza and RSV epidemiology differed in many regards in Russia, especially in the timing of epidemics and the age distribution of infected subjects

Read more

Summary

Methods

We calculated the positivity rate for influenza and RSV (by month, season, and overall) in each city, separately for patients seen at the primary and secondary care level (out-patients medical centres housing GP practices and infectious diseases hospitals, respectively). We compared the age distribution of patients infected with the different influenza virus (sub)types and RSV. Surveillance of respiratory virus infections in Russia. Routine influenza surveillance was initially established in Russia in the late 1960s. The surveillance system collects weekly data on incidence, hospitalisations and deaths along with laboratory confirmation for influenza, RSV, and other respiratory viruses. Following the 2009 pandemic, the sentinel surveillance in Russia was divided for outpatients (influenza-like illness (ILI) cases) and hospitalised patients (severe acute respiratory infections (SARI) cases) according to the WHO recommendations and approved by the Rospotrebnadzor, and upgraded in 2010 to meet the recommendations of the WHO Regional Office for Europe. The influenza sentinel surveillance system is operated in ten cities across the country. Individual electronic case reporting forms (eCRF) are completed by clinicians under the supervision of the chief epidemiologists at each site, and integrated into a unified national database, which include information on patients’ demographics, influenza vaccination status, comorbidities, clinical symptoms, course of disease, and disease outcome

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call